Jordan Schlosser is a biotechnology entrepreneur, researcher, and full-stack builder whose career bridges bench science, venture creation, and cutting-edge software development. Trained in pharmacokinetic and pharmacodynamic (PK/PD) research, Jordan has led multidisciplinary teams investigating how novel therapeutics move through—and act within—the body, translating complex data into actionable clinical insights.

At Cornell Tech, Jordan served as an industry partner and mentor, guiding student-founders and faculty on commercialization pathways for life-science innovations. This role deepened his expertise in tech-transfer strategy and reinforced his passion for turning promising research into market-ready solutions.

Beyond the wet lab, Jordan has architected and deployed numerous Web3 applications, writing production-grade code in Python, Solidity, and Rust to power decentralized finance tools, token-based incentive models, and on-chain data pipelines. His cross-disciplinary fluency lets him stitch together biology, cryptography, and cloud infrastructure into seamless user experiences.

Over the past decade, Jordan has founded and scaled multiple health-tech and biotech ventures, securing more than $28 million in equity and non-dilutive financing. Notably, he designed, built, and operated a state-of-the-art analytical laboratory specializing in PK/PD assay development. Under his leadership, the lab achieved GLP compliance, attracted a blue-chip client base, and was ultimately acquired by the publicly traded life-sciences company CanB—an exit that validated both the lab’s scientific rigor and commercial value.

Jordan combines deep scientific acumen with a proven ability to write code, build teams, raise capital, and execute growth strategies—skills he now channels into advising emerging biotech founders, investing in next-generation therapeutic platforms, and engineering the Web3 tools that will underpin the future of decentralized healthcare.

‍